The introduction of transcatheter pulmonary valve implantation (TPVI) has greatly benefited
the management of right ventricular outflow tract dysfunction. Infective endocarditis (IE) is a …

心脏瓣膜病治疗进展∗ Page 1 2022,38 临床心血管病杂志 (6):429-432
JournalofClinicalCardiology(China) ·专家论坛· 引用本文:董念国,曹红,周廷文,等.心脏瓣膜病治疗 …

Objectives The aim of this study was to demonstrate the safety and functionality of the Alterra
Adaptive Prestent and SAPIEN 3 transcatheter heart valve (THV) in patients with …

Transcatheter pulmonary valve replacement was first performed by Dr Philip Bonhoeffer,
who implanted a Medtronic Melody valve in a human in 2000. Over the past 2 decades …

Background: The Harmony transcatheter pulmonary valve (TPV) was designed for treatment
of postoperative pulmonary valve regurgitation in patients with repaired right ventricular …

Abstract Background and Aims Transcatheter pulmonary valve implantation (TPVI) is
indicated to treat right-ventricular outflow tract (RVOT) dysfunction related to congenital heart …

Abstract Background The Harmony transcatheter pulmonary valve (TPV) is the first US Food
and Drug Administration–approved device for severe pulmonary regurgitation (PR) in the …

Background Self-expanding pulmonary valve grafts have been designed for percutaneous
pulmonary valve implantation (PPVI) in patients with native repaired right ventricular (RV) …

Background: Balloon-expandable pulmonary valves are usually not suitable for dilated
native outflow tracts. Methods: Indian Venus P-valve registry was retrospectively analyzed …

Background Percutaneous pulmonary valve implantation (PPVI) with the self‐expandable
Venus P‐valve system is a promising treatment for patients with pulmonary regurgitation …